Cancer Genetics Inc (NASDAQ:CGIX)

7.60
Delayed Data
As of 1:40pm ET
 -0.09 / -1.17%
Today’s Change
4.83
Today|||52-Week Range
16.88
+13.77%
Year-to-Date

Today’s Trading

Previous close7.69
Today’s open7.72
Day’s range7.45 - 7.72
Volume19,604
Average volume (3 months)71,310
Market cap$75.5M
Dividend yield--
Data as of 1:40pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+50.55%
Earnings growth (this year)-12.57%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+54.30%
P/E ratioNM
Price/Sales6.19
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
TRILTrillium Therapeutic...+1.29+7.60%
GALTGalectin Therapeutic...+0.02+0.56%
GBIMGlobeImmune Inc+0.09+1.26%
TROVUTrovagene Inc0.000.00%
Data as of 1:46pm ET, 03/27/2015

Financials

Next reporting dateMay 14, 2015
EPS forecast (this quarter)-$0.53
Annual revenue (last year)$10.2M
Annual profit (last year)-$16.6M
Net profit margin-163.18%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
President, Chief Executive Officer &
Director
Panna L. Sharma
Vice President-
Operations
Robert Fannon
Corporate headquarters
Rutherford, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account